###begin article-title 0
###xml 19 24 <span type="species:ncbi:10090">Mouse</span>
MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology
###end article-title 0
###begin p 1
Conceived and designed the experiments: DN JM JA. Performed the experiments: JM DK SC AR DD HM SR. Analyzed the data: DN JM JA DK SC. Contributed reagents/materials/analysis tools: DN JM DK SC AR DD HM SR. Wrote the paper: JM JA.
###end p 1
###begin p 2
###xml 1828 1829 1828 1829 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1830 1831 1830 1831 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 416 424 <span type="species:ncbi:9606">patients</span>
###xml 565 573 <span type="species:ncbi:9606">patients</span>
###xml 810 825 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1130 1135 <span type="species:ncbi:9606">human</span>
###xml 1596 1602 <span type="species:ncbi:10090">murine</span>
Age-related increases in monoamine oxidase B (MAO-B) may contribute to neurodegeneration associated with Parkinson's disease (PD). The MAO-B inhibitor deprenyl, a long-standing antiparkinsonian therapy, is currently used clinically in concert with the dopamine precursor L-DOPA. Clinical studies suggesting that deprenyl treatment alone is not protective against PD associated mortality were targeted to symptomatic patients. However, dopamine loss is at least 60% by the time PD is symptomatically detectable, therefore lack of effect of MAO-B inhibition in these patients does not negate a role for MAO-B in pre-symptomatic dopaminergic loss. In order to directly evaluate the role of age-related elevations in astroglial MAO-B in the early initiation or progression of PD, we created genetically engineered transgenic mice in which MAO-B levels could be specifically induced within astroglia in adult animals. Elevated astrocytic MAO-B mimicking age related increase resulted in specific, selective and progressive loss of dopaminergic neurons in the substantia nigra (SN), the same subset of neurons primarily impacted in the human condition. This was accompanied by other PD-related alterations including selective decreases in mitochondrial complex I activity and increased mitochondrial oxidative stress. Along with a global astrogliosis, we observed local microglial activation within the SN. These pathologies correlated with decreased locomotor activity. Importantly, these events occurred even in the absence of the PD-inducing neurotoxin MPTP. Our data demonstrates that elevation of murine astrocytic MAO-B by itself can induce several phenotypes of PD, signifying that MAO-B could be directly involved in multiple aspects of disease neuropathology. Mechanistically this may involve increases in membrane permeant H2O2 which can oxidize dopamine within dopaminergic neurons to dopaminochrome which, via interaction with mitochondrial complex I, can result in increased mitochondrial superoxide. Our inducible astrocytic MAO-B transgenic provides a novel model for exploring pathways involved in initiation and progression of several key features associated with PD pathology and for therapeutic drug testing.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 117 120 117 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Westlund1">[1]</xref>
###xml 121 124 121 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Levitt1">[3]</xref>
###xml 242 245 242 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Saura1">[4]</xref>
###xml 246 249 246 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Gerlach1">[7]</xref>
###xml 350 351 350 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 352 354 352 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 354 357 354 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Vindis1">[8]</xref>
###xml 359 362 359 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Cohen1">[9]</xref>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Adams1">[10]</xref>
###xml 674 675 674 675 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 676 677 676 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 819 823 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Halliwell1">[11]</xref>
###xml 1041 1042 1041 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1043 1044 1043 1044 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1164 1165 1164 1165 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1166 1167 1166 1167 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1181 1185 1181 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Halliwell1">[11]</xref>
###xml 1186 1190 1186 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Kang1">[15]</xref>
###xml 1331 1335 1331 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Buckman1">[16]</xref>
###xml 1336 1340 1336 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Whittemore1">[18]</xref>
###xml 1362 1363 1362 1363 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1364 1365 1364 1365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1432 1433 1432 1433 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1525 1529 1525 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Wei1">[19]</xref>
###xml 1683 1687 1683 1687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Damier1">[20]</xref>
###xml 226 232 <span type="species:ncbi:9606">humans</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
Monoamine oxidase B (MAO-B) is found in the brain primarily in non-neuronal cells such as astrocytes and radial glia [1]-[3]. Its levels are known to increase with age and in association with neurodegenerative disease in both humans and mice [4]-[7]. Substrate oxidation by the enzyme is accompanied stoichiometrically by the reduction of oxygen to H2O2 [8], [9]. It has been postulated that age-related increases in MAO-B activity may contribute to cellular degeneration in the brain due to corresponding increases in the production of this reactive oxygen species (ROS)[10]. Although MAO-B is expressed primarily in astrocytes and not directly within dopaminergic cells, H2O2 has a high membrane permeability and therefore it can induce toxic effects not only within the cell of origin, but also in neighboring cells [11]. The area of the brain preferentially impacted in Parkinson's disease (PD), the substantia nigra (SN), contains high levels of MAO-B positive astrocytes which are themselves somewhat protected against the effects of H2O2 due to the fact that they contain high levels of both GSH and glutathione peroxidase which act in concert to detoxify H2O2 within cells [11]-[15]. Neurons, which contain significantly lower levels of these protective components, are particularly vulnerable to this mild oxidizing agent [16]-[18]. This suggests that H2O2 produced within astrocytes by MAO-B may be either broken down to H2O within these cells or may diffuse to vulnerable nearby cells such as dopaminergic neurons [19]. MAO-B activity levels have been found to be doubled in the SN in Parkinson's disease, and to correlate with the percentage of dopaminergic SN cell loss [20]. This suggests that increases in MAO-B levels could play a role in subsequent dopaminergic cell death.
###end p 4
###begin p 5
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Soong1">[21]</xref>
###xml 153 161 153 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 222 223 222 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 224 225 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Kumar1">[22]</xref>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Betarbet1">[23]</xref>
###xml 769 773 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Przedborski1">[24]</xref>
###xml 825 826 825 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 859 860 859 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1057 1061 1057 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Gainetdinov1">[25]</xref>
###xml 736 741 <span type="species:ncbi:9606">human</span>
MAO-B-catalyzed ROS production has been suggested to contribute to an age-related increase in mitochondrial damage particularly in the SN [21]. Previous in vitro studies from our laboratory demonstrated that increases in H2O2 generation as a consequence of inducible increases in MAO-B levels results in selective inhibition of mitochondrial complex I activity which impacted on mitochondrial function within cultured dopaminergic cells [22]. Selective reductions in complex I activity are associated with PD and selective inhibition of complex I via systemic administration of either rotenone or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) results in patterns of morphological damage in rodents similar to that observed in the human Parkinsonian midbrain[23], [24]. MAO-B is responsible for conversion of MPTP to MPP+ within astrocytes from where MPP+ can diffuse extracellularly. From there, it can be selectively transported into dopaminergic neurons via the dopamine transporter and elicit inhibitory effects on mitochondrial complex I activity [25].
###end p 5
###begin p 6
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Wu1">[26]</xref>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Szende1">[28]</xref>
###xml 581 585 581 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Shoulson1">[29]</xref>
###xml 586 590 586 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Schneider1">[31]</xref>
###xml 631 635 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-ParkinsonStudyGroup1">[32]</xref>
###xml 921 925 909 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Fearnley1">[33]</xref>
###xml 440 448 <span type="species:ncbi:9606">patients</span>
###xml 759 767 <span type="species:ncbi:9606">patients</span>
###xml 1477 1482 <span type="species:ncbi:10090">mouse</span>
###xml 1749 1753 <span type="species:ncbi:10090">mice</span>
###xml 1819 1824 <span type="species:ncbi:9606">human</span>
There are numerous reports demonstrating the neuroprotective effects of the MAO-B inhibitors deprenyl or selegiline in Parkinsonian animal models although in many cases neuroprotection has been attributed to either antioxidant or antiapoptotic properties of the parent compounds or their metabolites [26]-[28]. Several multi-center studies including DATATOP, addressing the efficacy of selegiline administration in Parkinson's disease (PD) patients have concluded that selegiline both delayed and reduced the requirement of L-DOPA supplementation in early stages of symptomatic PD [29]-[31] but had no effect on the mortality rate [32]. Although deprenyl was found to be ineffective in slowing or halting the ultimate mortality in clinical PD it was given to patients only after symptoms were present which is known to coincide with the presence of an already extensive (approximately60%) midbrain dopaminergic cell loss [33]. These studies suggest that inhibition of MAO-B activity at this advanced stage in the disease is ineffective but this does not necessarily prove that MAO-B elevation is not a factor in initial neuropathology associated with the disorder and MAO-B inhibitors if given pre-symptomatically might not be protective. In order to test the hypothesis that elevations in MAO-B can directly contribute to pathologies observed in PD and to better understand the possible mechanisms underlying its effects on these parameters, we created genetically engineered mouse lines in which MAO-B levels can be inducibly increased specifically within astrocytes in adult animals. This allowed us to bypass any impact of its increased expression during the developmental time period. We report here that astrocytic elevation of MAO-B in adult mice recapitulates many of the pathological hallmarks associated with human PD and that these effects can be prevented by treatment with the selective MAO-B inhibitor deprenyl or the antioxidant EUK189.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
Creation of transgenic mouse lines in which astrocytic MAO-B activity can be inducibly increased in adult animals
###end title 8
###begin p 9
###xml 542 551 542 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g001">Figure 1A</xref>
###xml 690 699 690 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g001">Figure 1B</xref>
###xml 881 890 881 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g001">Figure 1C</xref>
###xml 1241 1250 1241 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g001">Figure 1D</xref>
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
###xml 428 433 <span type="species:ncbi:9606">human</span>
###xml 652 657 <span type="species:ncbi:10090">mouse</span>
###xml 1124 1129 <span type="species:ncbi:9606">human</span>
Double transgenic mouse lines were generated in our laboratory that constitutively express a reverse tetracycline responsive transactivator (rtTa) protein specifically within astrocytes via a glial fibrillary acidic protein promoter (pGFAP). Upon addition of the tetracycline derivative doxycycline (dox), rtTa binds to a tetracycline responsive bidirectional promoter (TET) and induces simultaneous expression of both wildtype human MAO-B cDNA (GenBank accession number NM 000898) and the marker protein bacterial beta-galactosidase (lacZ) (Figure 1A). Expression of the two co-transgenes was induced in our studies via inclusion of dox in the normal mouse chow, and visualized by RT-PCR (Figure 1B). Whole brain extracts from induced animals with the highest levels of expression exhibited an approximate 2.5-fold increase in MAO-B and lacZ activities versus uninduced controls (Figure 1C); increased MAO-B activity was completely inhibited by deprenyl treatment (data not shown). This high-expressing line was used for all subsequent studies. Immunohistochemistry using antibodies specific to MAO-B demonstrated that the human MAO-B was exclusively expressed within (GFAP) astroglia throughout the brain and only following dox treatment (Figure 1D).
###end p 9
###begin title 10
###xml 20 35 <span type="species:ncbi:10090">transgenic mice</span>
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 160 175 <span type="species:ncbi:10090">transgenic mice</span>
###xml 204 209 <span type="species:ncbi:9606">human</span>
Characterization of transgenic mice that inducibly express human MAO-B specifically within astrocytes. A. Schematic of transgenic constructs utilized to create transgenic mice with inducible elevation of human MAO-B (h-MAO-B) expression specifically within astrocytes via the bacterial tetracycline regulatory system.
###end title 10
###begin p 11
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtetR)</italic>
###xml 424 429 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAO-B</italic>
###xml 1594 1595 1580 1581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2315 2316 2301 2302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2633 2634 2619 2620 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2680 2682 2664 2666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
###xml 507 512 <span type="species:ncbi:9606">Human</span>
###xml 564 579 <span type="species:ncbi:10090">transgenic mice</span>
###xml 756 771 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1430 1434 <span type="species:ncbi:10090">mice</span>
###xml 1539 1544 <span type="species:ncbi:9606">human</span>
###xml 2429 2433 <span type="species:ncbi:10090">mice</span>
###xml 2445 2460 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2462 2464 <span type="species:ncbi:10090">ND</span>
###xml 2610 2612 <span type="species:ncbi:10090">ND</span>
###xml 2703 2705 <span type="species:ncbi:10090">ND</span>
###xml 2706 2710 <span type="species:ncbi:10090">mice</span>
A bacterial reverse tetracycline response gene (rtetR) was expressed constitutively via a mouse glial fibrillary acidic protein promoter (pGFAP). The resulting gene product, rtTA, a tet-responsive transactivator protein, is activated only in the presence of doxycycline (dox) and is able to bind to a tetracycline operator (TET) sequence in the promoter of a second transgene, resulting in induction of expression of both h-MAO-B and bacterial beta-galactosidase (lac Z) from the bidirectional promoter. B. Human MAO-B cDNA transgene is expressed in the brains of transgenic mice following dox induction. Inducible transgene mRNA expression (a 448 bp amplicon) was visualized by RT-PCR from RNA isolated from whole brains of uninduced (U), dox-induced (I) transgenic mice and wild type littermates (W). C. Enzymatic activities of h-MAO-B and lacZ transgenes in whole brain lysates from uninduced (ND) and dox-induced (D) transgenic animals. n = 3 animals per condition run in triplicate; * p<0.01. Data is presented as percent ND control. ND lacZ activity was calculated to be 11.9+/-0.54 nmoles ONPG converted/mg protein/hour and wild type C57BL6 lacZ activity (not shown) to be 11.3+/-0.13 nmoles ONPG converted/mg protein/hour respectively. Brain MAO-B activity in tissue isolated from the uninduced transgenic (ND) was calculated to be 14.6+/-0.9 nmoles beta-PEA converted/mg protein/hour and in tissues from wild type C57BL6 mice (not shown) to be 14.2+/-0.23 nmoles beta-PEA converted/mg protein/hour. D. Dox-inducible expression of human MAO-B (h-MAO-B) and lacZ is localized within GFAP+ astrocytes. GFAP immunostaining is shown in green, h-MAO-B is red, and merged in yellow in uninduced (No DOX) and dox-induced (DOX) animals. Scale bar applies to all images. E. Loss in striatal dopamine (ST DA) content is exacerbated in dox-induced transgenics following a single MPTP injection of 30 mg/kg body weight. Striatal dopamine was estimated from wild type (W), uninduced transgenics (ND), induced transgenics (D), and dox-induced transgenics co-treated with deprenyl (Ddep). Grey bars without MPTP, black bars after a single injection of 30 mg/kg MPTP. Data is expressed as ng dopamine/mg striatal protein. * p<0.01 D vs. ND, ** = p<0.01 Ddep vs. ND. F. Loss in dopaminergic tyrosine-hydroxylase-positive (TH+) neurons in the substantia nigra (SN) after a single injection of MPTP (30 mg/kg) is exacerbated in dox-induced mice. Uninduced transgenic mice (ND), induced transgenics (Dox), and induced transgenics co-treated with 10mg/kg deprenyl (Doxdep). Data is presented as percent of non-MPTP treated ND controls where SN TH+ cell numbers are estimated at 13,318+/-475 TH+ neurons in untreated ND mice (WT values, not shown, were 13,699+/-325). n = 3 animals per condition run in triplicate; * p<0.05.
###end p 11
###begin title 12
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Elevation in astrocytic MAO-B results in increased conversion of MPTP to MPP+ and significant increases in toxin-induced dopaminergic SN cell loss
###end title 12
###begin p 13
###xml 175 176 175 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 298 299 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 503 504 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 531 538 531 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001616-t001">Table 1</xref>
###xml 588 589 588 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 711 712 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 897 912 897 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g001">Figures 1E &amp; 1F</xref>
###xml 1016 1025 1004 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g001">Figure 1E</xref>
###xml 407 422 <span type="species:ncbi:10090">transgenic mice</span>
To validate that our transgenic model expresses functionally active MAO-B, we assessed its vulnerability to acute systemic MPTP administration. Since conversion of MPTP to MPP+ is catalyzed by MAO-B, we predicted that elevation in functional astrocytic MAO-B should result in increased striatal MPP+ levels and exacerbation of selective MPTP-induced dopaminergic SN neurodegeneration. Induced and uninduced transgenic mice and wildtype C57Bl6 littermates were treated with 30 mg/kg MPTP and striatal MPP+ levels measured via HPLC (Table 1). At 90 minutes post MPTP injection, striatal MPP+ levels were 1.5-1.8-fold that observed in either uninduced transgenic or wildtype controls. This increase in striatal MPP+ was accompanied by a significant decrease in striatal dopamine levels and dopaminergic SN cell numbers in induced transgenics compared to controls seven days following MPTP treatment (Figures 1E & 1F). MAO-B elevation alone was found to result in approximately60% reduction in striatal dopamine levels (Figure 1E) which was exacerbated further by MPTP. Elevations in astrocytic MAO-B in our transgenics resulted in exacerbation of MPTP-induced neurotoxicity suggesting that astrocytic MAO-B increases had the expected functional effect.
###end p 13
###begin title 14
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Striatal MPP+ levels.
###end title 14
###begin p 15
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 215 216 215 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 365 366 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 117 132 <span type="species:ncbi:10090">transgenic mice</span>
MPP+ levels were measured in striatal tissues collected from wildtype (WT), uninduced (No dox) and dox-induced (Dox) transgenic mice 90 min post-MPTP injection (30 mg/kg) via HPLC with electrochemical detection. MPP+ was extracted from tissues homogenized in the presence of 0.4N perchloric acid and measured against a known standard. Values are presented as ng MPP+/mg protein , n = 3 per treatment condition.
###end p 15
###begin p 16
###xml 679 680 675 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 793 802 789 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g002">Figure 2A</xref>
###xml 1007 1008 1003 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1193 1194 1189 1190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1303 1304 1283 1284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1801 1810 1781 1790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g002">Figure 2B</xref>
###xml 205 220 <span type="species:ncbi:10090">transgenic mice</span>
Astrocytic MAOB elevation in mesencephalic cultures isolated from inducible MAO-B lines was found to result in dopaminergic neurodegeneration. Mesencephalic cultures were prepared from day-14 embryos from transgenic mice and wildtype littermates. Mixed neuronal/glial mesencephalic cultures were grown on coated plates for 3 days and transgenic MAO-B activity induced in a portion of the transgenic cultures by addition of 40 microg/ml dox. Dox was added to wildtype cultures as a negative control. Twelve hours following dox addition, immunocytochemistry performed on dox-induced transgenic cultures revealed a significant loss in the number of tyrosine hydroxylase positive (TH+) cells compared to controls even in the absence of toxin addition that was attenuated by deprenyl co-treatment (Figure 2A). To verify that loss of TH immunostaining represents actual preferential loss of dopaminergic cells, we counted the number of cells within the cultures which take up the fluorescent dopamine analogue ASP+ (4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide, Molecular Probes) as a measure of cells with functional dopamine transporter activity. We found a similar percentage loss of ASP+ cells (approximately80%, 44+/-22 versus 244+/-68 uninduced per field). This demonstrates that the loss in TH+ cell numbers is not simply a consequence of selective loss of this particular marker. In addition to increased dopaminergic cell loss, the remaining dopaminergic neurons were observed to undergo significant loss of their neurite processes which became stunted and shrunken in size. Deprenyl co-treatment attenuated not only the extensive dopaminergic cell loss observed following induction of MAO-B within cultured astrocytes but also the observed morphological dopaminergic neurite alterations (Figure 2B).
###end p 16
###begin title 17
###xml 116 117 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 183 184 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 416 418 412 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-6</sup>
###xml 87 102 <span type="species:ncbi:10090">transgenic mice</span>
###xml 304 306 <span type="species:ncbi:10090">ND</span>
Inducible elevation of astrocytic MAO-B levels in mesencephalic cultures isolated from transgenic mice results in TH+ cell loss which is prevented by co-treatment with deprenyl. A. TH+ cell counts in uninduced mesencephalic cultures isolated from either wildtype littermates (WT), uninduced transgenics (ND) or transgenic cultures induced with 40 microg/ml doxycycline for 24 hrs in the absence (D) or presence of 10-6M deprenyl (Ddep).
###end title 17
###begin p 18
###xml 74 75 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 278 279 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 300 301 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 209 211 <span type="species:ncbi:10090">ND</span>
Counts are expressed as % WT values which were estimated to be 300+/-15 TH+ neurons. Cell counts were performed in a minimum of three different wells and 4 separate fields in each well. * = p<0.01 compared to ND; **p>0.01 compared to Dox. B. Representative micrographs of the TH+ cells obtained by TH+ immunofluorescence in uninduced (No Dox), dox-induced (Dox) and dox-induced mesencephalic cultures treated with deprenyl (Doxdep). Note the truncated processes and shrunken dopaminergic cell morphology in the induced cultures versus uninduced and deprenyl-treated induced cultures.
###end p 18
###begin title 19
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Elevations of astrocytic MAO-B in vivo results in selective dopaminergic SN cell loss
###end title 19
###begin p 20
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 438 447 438 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g003">Figure 3A</xref>
###xml 574 576 574 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 1027 1037 1015 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g003">Figures 3B</xref>
###xml 1209 1222 1197 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g003">Figures 3C, D</xref>
###xml 1755 1764 1740 1749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g003">Figure 3E</xref>
###xml 164 179 <span type="species:ncbi:10090">transgenic mice</span>
To assess the impact of astrocytic MAO-B elevation on its own in vivo on the nigrostriatal system, stereological dopaminergic cell counts were performed on dox-fed transgenic mice versus controls. A two week induction period in 2-3 month old transgenics resulted in an approximate 40% loss in dopaminergic SN cell numbers compared to either untreated transgenics or wildtype littermates; this loss was prevented by deprenyl co-treatment (Figure 3A). Moreover, removal of dox from the animal feed after the initial two weeks for three weeks did not result in a reversal of TH+ counts to normal levels. Astrocytic MAO-B elevation in older (14 mo.) transgenics resulted in an even more pronounced dopaminergic SN cell loss (approximately50%) than that observed in the younger animals. In contrast, total neuronal numbers in the SN as assessed by NeuN staining did not differ between dox-treated transgenics versus untreated controls nor were neuronal cell numbers in the striatum or cortex impacted by astrocytic MAO-B elevation (Figures 3B), even though it occurred throughout the brain and resulted in a general and widespread astrogliosis as evidenced by GFAP immunocytochemistry in these same brain regions (Figures 3C, D). GABAergic SN cell counts also revealed no difference in dox-induced versus non-induced animals further suggesting that the observed dopaminergic cell loss in this brain region was selective (data not shown). GFAP immunostaining revealed profuse branching as normally observed following astroglial activation and increased astroglial brain numbers following dox treatment which were inhibited by deprenyl. Levels of S100-beta, a marker for activated astrocytes, were also increased in transgenic astroglia following dox induction (Figure 3E).
###end p 20
###begin title 21
###xml 180 181 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Inducible elevation in astrocytic MAO-B results in selective, age-related SN dopaminergic neurodegeneration and global astrocyte activation even in the absence of neurotoxin. A. TH+ SN cell counts from uninduced transgenics (no dox) versus induced transgenics at 3-4 months (dox) , following dox removal (dox rem) at 14 months of age (dox 14 mo), and induced co-treated with deprenyl at 10-30 mg/kg (dox dep 10-30), the anti-inflammatory agent minocycline at 10 mg/kg (dox mino) or the anti-oxidant Euk189 at 10 mg/kg in young animals.
###end title 21
###begin p 22
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1014 1015 1014 1015 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1587 1588 1584 1585 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1782 1783 1776 1777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1905 1906 1899 1900 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2069 2070 2063 2064 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 90 92 <span type="species:ncbi:10090">ND</span>
###xml 606 608 <span type="species:ncbi:10090">ND</span>
###xml 1117 1121 <span type="species:ncbi:10090">mice</span>
Data is expressed as total number of SN TH+ cells numbers per animal; *p<0.01 compared to ND, ** p< 0.05 compared to Dox, and *** p< 0.05 compared to dox. B. Neuronal (NeuN+) counts from uninduced (No Dox, filled bars) versus dox-induced transgenics (Dox, open bars) performed in equivalent nigral (SN), cortical (CT), and striatal (ST) tissue sections. Values represent average cell numbers per field in three separate fields per section, three sections per animal. N = 5 animals per group. C. Representative micrographs demonstrating cortical astrocytic activation in dox-induced (Dox) versus uninduced (ND) animals and dox-induced animals co-treated with deprenyl (Ddep). Astrocytes from induced transgenics displayed enhanced GFAP staining and increased branching indicative of astrocyte activation (higher magnification in lower middle panel); deprenyl treatment resulted in reduced branching similar to that observed in uninduced controls (higher magnification in lower right-hand panel). D. Astrocytic (GFAP+) counts from uninduced (No DOX, open bars) versus dox-induced transgenics (DOX, light grey bars) and mice dox-induced in the presence of deprenyl co-treatment (D DEP, dark grey bars) performed in equivalent striatal (ST), nigral (SN), and cortical (CT) tissue sections. Values represent average cell numbers per field at 40xmagnification in three separate fields per section, three sections per animal. N = 5 animals per group; *p>0.05, ** p<0.1. E. Representative micrograph demonstrating increased expression of the astrocytic activation marker S-100beta (blue) in GFAP+ cells in the transgenic cortex following dox induction. GFAP-labeled astrocytes (red) in induced animals display increased S-100beta staining (pink) versus uninduced. F. Neurodegeneration of TH+ cells as assessed by silver staining. SN sections from uninduced (No Dox) and induced (Dox) animals were processed for TH+ immunoreactivity visualized by alkaline peroxidase (blue) and further processed for silver staining. A black punctate staining was observed in and around dying TH+ neurons (arrows) in Dox but not No Dox fields.
###end p 22
###begin p 23
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 185 194 185 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g003">Figure 3F</xref>
###xml 274 275 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 343 344 343 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
We performed silver staining to verify that selective loss of TH+ immunostained cells in the SN following dox induction coincided with increased neurodegeneration in this brain region (Figure 3F). This data along with the dox removal results suggests that the decrease in TH+ SN cells is not merely due to a reversible selective loss of the TH+ marker but constitutes an irreversible dopaminergic SN neurodegeneration.
###end p 23
###begin title 24
Astrocytic MAO-B elevations result in increased mitochondrial oxidative stress in dopaminergic SN neurons
###end title 24
###begin p 25
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Zoccarato1">[34]</xref>
###xml 484 485 484 485 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 532 533 532 533 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 533 534 533 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 683 684 683 684 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 684 685 684 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 848 849 848 849 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 850 851 850 851 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1178 1179 1178 1179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1180 1181 1180 1181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1312 1313 1312 1313 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1314 1315 1314 1315 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1442 1450 1442 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g004">Figure 4</xref>
###xml 1521 1522 1521 1522 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1523 1524 1523 1524 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1715 1716 1715 1716 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1717 1719 1717 1719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 1945 1946 1945 1946 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Based on our data, global increases in astrocytic MAO-B appeared to result in a preferential neurodegeneration of dopaminergic neurons suggesting that dopamine itself may be involved in the neurodegenerative process. Recent work in isolated brain mitochondria [34] demonstrated that dopamine oxidized to dopaminochrome (DACHR) can remove electrons from the auto-oxidizable site in mitochondrial complex I forming dopaminochrome radical. Dopaminochrome radical can in turn react with O2 present in the mitochondria converting it to O2- in concert with re-reduction of the dopaminergic radical, setting up a redox cycling event. This would be manifest as an increase in mitochondrial O2- levels and ROS-induced complex I inhibition within the dopaminergic neurons which could result in their selective demise. We hypothesized that membrane-permeant H2O2 produced by increased MAO-B activity within astrocytes could interact with intercellular dopamine and produce selective degenerative effects on dopaminergic neurons via a similar mechanism. To first test for the ability of astrocytes with elevated MAO-B activity to produce increased levels of extracellular ROS, we measured H2O2 generated in the culture medium in mesencephalic cultures isolated from our inducible MAO-B transgenics following dox induction. H2O2 levels released into the media in dox-induced cultures were significantly higher than those produced from untreated cultures (Figure 4). Co-treatment with deprenyl prevented the increase in extracellular H2O2 as did treatment with the antioxidant superoxide dismutase-catalase mimetic compound EUK-189. Co-treatment with apocynin, an NADPH oxidase inhibitor, resulted in a partial reduction in the H2O2 levels indicating that microglial activation contributes to the ROS increase although it is not clear whether this is directly due to astroglial activation or a secondary effect of dopaminergic cell death in the cultures. Iba1+ cells (a 17 kDa calcium binding protein expressed in microglia) were found to constitute 3% of the total cell population and their numbers were increased by approximately17% following dox induction (data not shown).
###end p 25
###begin title 26
###xml 85 86 85 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Elevation in astrocytic MAO-B results in increased extracellular hydrogen peroxide (H2O2).
###end title 26
###begin p 27
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 17 19 17 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 280 281 272 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 282 283 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 335 336 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 337 338 329 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 82 84 <span type="species:ncbi:10090">ND</span>
###xml 469 471 <span type="species:ncbi:10090">ND</span>
###xml 495 497 <span type="species:ncbi:10090">ND</span>
Extracellular H2O2 concentrations were measured in media isolated from uninduced (ND) versus dox-induced (Dox) mesencephalic cultures in the absence and presence of 10 microM deprenyl (Dox Dep), 30 microM EUK189 (Dox Euk) or 500 nM apocynin (Dox Apo) using the Amplex Red assay. H2O2 concentrations were quantified against a standard H2O2 curve. Measurements were made on three separate media aliquots harvested prior to immunostaining of cultures; *p<0.01 compared to ND, ** p<0.05 compared to ND.
###end p 27
###begin p 28
###xml 292 296 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Pickel1">[35]</xref>
###xml 297 301 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Nirenberg2">[37]</xref>
###xml 390 391 378 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 392 393 380 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 642 651 630 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g005">Fig. 5A,B</xref>
###xml 724 725 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Dopaminergic neurons constitute only a minor portion (approximately 5%) of cells making up the SN (unpublished observations). In contrast to the SN, the striatum (ST) is larger, easier to dissect out, and at least 10-15% of the striatal nerve terminals originate from SN dopaminergic neurons [35]-[37]. In order to achieve meaningful data as to the impact of astrocytic MAO-B elevation on H2O2 levels and mitochondrial function selectively within dopaminergic nigrostriatal neurons, we chose to enrich for striatal dopaminergic nerve terminal (synaptosomal) populations using antibody against DAT via a modified immunomagnetic bead approach (Fig. 5A,B). Synaptosomes in the flow-through fractions were non-dopaminergic (GABA+) and therefore used as negative controls in our subsequent biochemical analyses.
###end p 28
###begin title 29
###xml 46 47 46 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 48 49 48 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Effects of elevations of astrocytic MAO-B on H2O2 and dopaminochrome (DAChr) levels, and mitochondrial complex I versus IV activities in isolated ST dopaminergic versus non-dopaminergic synaptosomes. A. Schematic of novel immunomagnetic technique utilized to for isolate ST dopaminergic versus non-dopaminergic synaptosomes.
###end title 29
###begin p 30
###xml 996 997 996 997 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 998 999 998 999 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1038 1039 1038 1039 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1040 1041 1040 1041 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2974 2978 2956 2960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Yadava1">[62]</xref>
###xml 1159 1161 <span type="species:ncbi:10090">ND</span>
###xml 1308 1311 <span type="species:ncbi:9685">Cat</span>
###xml 1492 1494 <span type="species:ncbi:10090">ND</span>
###xml 1649 1651 <span type="species:ncbi:10090">ND</span>
###xml 1678 1693 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2028 2030 <span type="species:ncbi:10090">ND</span>
###xml 2259 2261 <span type="species:ncbi:10090">ND</span>
###xml 2285 2287 <span type="species:ncbi:10090">ND</span>
###xml 2367 2369 <span type="species:ncbi:10090">ND</span>
###xml 2441 2444 <span type="species:ncbi:176652?0.2872340425531915">CIV</span>
###xml 2536 2538 <span type="species:ncbi:10090">ND</span>
###xml 2761 2764 <span type="species:ncbi:176652?0.2872340425531915">CIV</span>
###xml 3114 3118 <span type="species:ncbi:10090">mice</span>
Synaptosomes were prepared from freshly dissected striata and the dopaminergic population rapidly isolated via immunoprecipitation with anti-DAT antibody following by separation by a magnetic particle-conjugated secondary antibody running through a strong magnetic column. Elution of the DA synaptosomes was obtained via removal of the magnetic field. Flow-through contains striatal non-dopaminergic synaptosomes used as negative controls in subsequent biochemical experiments. B. Densitometric quantitation of western blot analyses of fractions from immunomagnetic isolation of ST synaptosomes probed with TH, GABA or SNAP-25 antibodies. Levels of Dopaminergic TH (grey bars) versus Non-dopaminergic GABA (white bars) synaptosomes were assessed using SNAP-25, a general synaptic protein, as a loading control. Control (C), unbound fraction (U), flow-through (FT), wash (W) and eluate (E). Representative blots are shown in the lower panel. C. Elevation in astrocytic MAO-B results in increased H2O2 within dopaminergic ST synaptosomes. H2O2 levels were estimated 3 hrs following tail vein injection of DCFDA into either wildtype littermates (WT), uninduced (ND) or dox-induced (Dox) transgenics, or induced transgenic animals co-treated with either deprenyl (D DEP), EUK189 (D EUK) or 1 mg/ml catalase (Dox Cat). DCF fluorescence was examined at an excitation wavelength of 488 nm and emission at 512 nm. Data is reported normalized to microgram synaptosomal protein. N = 3; *p<0.005 versus ND, ** = p<0.01 versus Dox. D. Elevation in astrocytic MAO-B results in increased ST DAChr levels. DAChr levels were estimated in ST samples from uninduced (ND) versus dox-induced (Dox) transgenic mice via HPLC. Values are presented as picomoles DAChr/mg protein.* p<0.02, n = 3. E. Elevation in astrocytic MAO-B results in decreased complex I but not complex IV activity in ST dopaminergic synaptosomes. Complex I and complex IV activities were measured in isolated ST dopaminergic versus non-dopaminergic synaptosomes from uninduced (ND), dox-induced (Dox) and induced transgenic animals co-treated with either deprenyl (Dep) or EUK-189 (EUK). N = 3-5 animals per group and a total of 3 separate experiments, values are expressed as mean+/-SD; * p<0.01 compared to ND, ** p>0.05 compared to ND. CI activity was calculated to be 4.0 versus 3.3 microM NADH/min/mg protein in ND striatal dopaminergic and non-dopaminergic synaptosomes, respectively. CIV activity was calculated to be 139 versus 109 microM ferrocytochrome c/minute/mg protein in ND striatal dopaminergic and non-dopaminergic synaptosomes, respectively. Activities of WT DA striatal synaptosomes was calculated to be 4.4 microM NADH/min/mg protein (CI) and 130 microM ferrocytochrome c/minute/mg protein (CIV); dox feeding of the WT animals did not alter the activities. Note: addition of doxycycline has been reported to interfere with mitochondrial protein translation including CI thereby affecting enzyme activity [62], however in addition to lack of effect on CI activity in WT animals +/- dox, we also find no change in CI subunit protein levels in WT mice as a consequence of dox treatment as assessed via immunoprecipitation/gel electrophoretic analyses (data not shown).
###end p 30
###begin p 31
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Andrews1">[38]</xref>
###xml 217 218 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 219 220 219 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 435 442 435 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g005">Fig. 5C</xref>
###xml 621 622 621 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 623 624 623 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 661 662 661 662 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 663 664 663 664 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 870 874 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Ochs1">[39]</xref>
###xml 876 885 876 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g005">Figure 5D</xref>
###xml 1069 1078 1069 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g005">Figure 5E</xref>
###xml 1186 1195 1186 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g005">Figure 5E</xref>
H2O2 levels were measured in isolated ST dopaminergic synaptosomes following injection of DCF into the tail vein of dox-induced versus uninduced and wildtype littermate controls as modified from Andrews et al. [38]. H2O2 levels was found to be elevated in isolated ST dopaminergic synaptosomes following increased astrocytic MAO-B elevation; this was found to be preventable by co-treatment of animals with either deprenyl or EUK-189 (Fig. 5C). Catalase treatment of the dopaminergic synaptosomes from the induced animals reduced the fluorescence to below uninduced levels indicating that the DCF fluorescence is due to H2O2. In conjunction with elevations in H2O2 within nerve terminals originating from dopaminergic SN neurons, we found an elevation in striatal DACHR. DACHR is a stable derivative of dopamine quinone, the major species produced by dopamine oxidation [39] (Figure 5D). Along with increases in DACHR levels, we found a preferential reduction in rotenone-inhibitable complex I (CI) activity in the ST dopaminergic versus non-dopaminergic synaptosomes (Figure 5E). In contrast, no change in complex IV activity was observed in either population following dox-induction (Figure 5E). Loss of CI activity was attenuated in dopaminergic synaptosomes isolated from dox-induced animals that had been co-treated with deprenyl or EUK-189.
###end p 31
###begin p 32
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 44 46 44 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 162 163 162 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 163 165 163 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722; </sup>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Zoccarato1">[34]</xref>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Andrews1">[38]</xref>
###xml 466 467 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 500 502 500 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 551 559 551 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g006">Figure 6</xref>
###xml 561 568 561 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001616-t002">Table 2</xref>
###xml 707 715 707 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g006">Figure 6</xref>
###xml 717 724 717 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001616-t002">Table 2</xref>
###xml 950 959 950 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g003">Figure 3A</xref>
To assess whether increased dopaminergic H2O2 and DACHR levels following astrocytic MAO-B elevation in vivo resulted in corresponding increases in mitochondrial O2- levels within dopaminergic cells as previously demonstrated in vitro by Zoccarato and colleagues [34], animals were administered the superoxide indicator mitosox red via tail vein injection[38]. Dox-induced transgenics displayed elevated presence of mitosox red staining within mitochondria in both TH+ fibers in the striatum and in TH+ neurons within the SN versus uninduced controls (Figure 6, Table 2). Increases in mitosox red fluorescence within the dopaminergic SN neurons were prevented by co-treatment with either deprenyl or EUK189 (Figure 6, Table 2). Significantly, dopaminergic SN cell loss was found to be attenuated in the presence of co-treatment with not only deprenyl, but also EUK189 suggesting that oxidative stress is an important component of dopaminergic demise (Figure 3A).
###end p 32
###begin title 33
Elevation in astrocytic MAO-B results in increased mitochondrial superoxide levels within dopaminergic SN mitochondria.
###end title 33
###begin p 34
###xml 261 276 <span type="species:ncbi:10090">transgenic mice</span>
###xml 278 281 <span type="species:ncbi:10090">Dox</span>
Representative confocal micrographs illustrating increased merged (yellow) mitosox red fluorescence (red) in the SN and striatum of dopaminergic neurons following tail vein injection, fixation and TH immunochemistry (green) in uninduced (No Dox) versus induced transgenic mice (Dox) which is prevented in the presence of co-deprenyl (DEP) or EUK-189 (EUK) treatment. Nuclei are visualized via DAPI staining (blue).
###end p 34
###begin title 35
Superoxide in the SN dopaminergic neurons.
###end title 35
###begin p 36
###xml 100 102 <span type="species:ncbi:10090">ND</span>
###xml 123 138 <span type="species:ncbi:10090">transgenic mice</span>
Confocal quantitation of relative mitosox-red fluorescence intensity in SN DA neurons in untreated (ND) or dox-treated (D) transgenic mice in the absence or presence of deprenyl (DD) or EUK-189 (DEUK). Confocal images from immunofluorescent sections of brains were obtained following various treatment regimes and subjected to intensity measurements using the IMARIS software suite (Bitplane AG, Zurich, Switzerland) on selected cells from multiple sections from each treatment. Data is presented both as mean pixel intensity and total red fluorescent pixels (mitosox red) per cell.
###end p 36
###begin title 37
Increases in astrocytic MAO-B activity results in increased local microglial activation in the SN
###end title 37
###begin p 38
###xml 213 220 213 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g007">Fig. 7A</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-McGeer1">[40]</xref>
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Langston1">[41]</xref>
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-McGeer2">[42]</xref>
###xml 644 648 644 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Sherer1">[43]</xref>
###xml 743 747 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Peng1">[44]</xref>
###xml 869 873 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Imai1">[45]</xref>
###xml 1135 1139 1135 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Stence1">[46]</xref>
###xml 1251 1259 1251 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g007">Figure 7</xref>
###xml 1296 1305 1296 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001616.s001">Figure S1</xref>
###xml 1642 1643 1642 1643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1687 1696 1687 1696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g007">Figure 7C</xref>
###xml 1763 1772 1763 1772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g007">Figure 7B</xref>
###xml 1999 2008 1999 2008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g003">Figure 3A</xref>
###xml 498 504 <span type="species:ncbi:9606">humans</span>
###xml 576 581 <span type="species:ncbi:10090">mouse</span>
###xml 730 735 <span type="species:ncbi:10090">mouse</span>
Data from our mitosox red studies not only suggested that SN dopaminergic neurons display an increase in oxidative stress following astrocytic MAO-B elevation, but also in the activated local SN microglial cells (Fig. 7A). This is likely a secondary effect subsequent to dopaminergic SN neurodegeneration triggering local microgliosis. Degeneration of SN dopaminergic neurons in PD has been observed to be accompanied by local microglial activation [40]. It has also been noted post-mortem in both humans and primates exposed to MPTP [41], [42]. It is detected in the chronic mouse rotenone model prior to appearance of the dopaminergic lesion [43] and during selective SN dopaminergic neurodegeneration in the spontaneous weaver mouse mutant [44]. We performed immunochemistry to evaluate microglial activation in our induced MAO-B transgenics via Iba1 immunostaining [45]. Prior to activation, microglia normally exhibit a highly ramified morphology. In response to an activating signal, microglia begin to withdraw their ramified branches and to extend new protrusions. Next they begin migration through the tissue, engulfing cells [46]. Astrocytic MAO-B expression was found to lead to local microglial activation in both the SN and the striatum (Figure 7 B-D) but not the cortex (supplement Figure S1). Unactivated ramified microglia were found in the uninduced nigrostriata and cortex; activated microglia with reduced branching in locomotory stages were only present within the SN and striatum of induced MAOB transgenics. In some cases, the microglia were in a high motile state with minimal processes or were in close contact with TH+ neurons, possibly in the phagocytic stage (Figure 7C). Microglial activation was prevented by treatment with deprenyl (Figure 7B). Co-treatment of animals with an inhibitor of microglial activation, minocycline, prevented dopaminergic SN cell death suggesting that microglial activation plays a major role in dopaminergic neurodegeneration in this model (Figure 3A).
###end p 38
###begin title 39
Global elevation in astrocytic MAO-B results in local SN microglial activation. A. Mitosox staining of local SN microglia following dox treatment reveals increased mitochondrial superoxide levels within these cells.
###end title 39
###begin p 40
###xml 542 543 542 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1143 1152 1139 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001616.s001">figure S1</xref>
###xml 449 452 <span type="species:ncbi:10090">Dox</span>
###xml 464 467 <span type="species:ncbi:10090">Dox</span>
###xml 633 636 <span type="species:ncbi:10090">Dox</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 673 676 <span type="species:ncbi:10090">Dox</span>
###xml 1321 1324 <span type="species:ncbi:10090">Dox</span>
###xml 1346 1349 <span type="species:ncbi:10090">Dox</span>
###xml 1481 1484 <span type="species:ncbi:10090">Dox</span>
###xml 1539 1542 <span type="species:ncbi:10090">Dox</span>
Microglia were immunostained with Iba1 (green) antibody in sections of brain fixed 3 hrs following tail injection of mitosox red. Confocal detail shows mitochondrial mitosox red fluorescence within an activated microglial cell body following dox induction. B. Microglial activation occurs following dox induction within the SN. Microglial activation as assessed by Iba1 immunochemistry (black, DAB-nickel staining) in SN sections from uninduced (No Dox), induced (Dox), and dox-induced co-deprenyl-treated transgenics (Ddep). Dopaminergic (TH+) neurons are labeled in brown (DAB). Note that few activated microglia are visible in No Dox and Ddep treated mice versus in the Dox panel where several stages of microglial activation (resting, activated, withdrawing, and motile stages) can be visualized. Scale bar equals 50 microM unless indicated otherwise. C. Higher magnification of representative SN Iba1 immunochemistry demonstrating stages of microglial activation (activated, withdrawing, and motile stages are indicated by cartoons). Cortical microglia were found to be in a ramified or resting stage in all the conditions (supplementary figure S1). D. Representative Iba1 immunochemistry in ST sections demonstrating increased microglial activation following dox induction. Shown are ST sections from uninduced (No Dox) versus dox-induced (Dox) or dox-induced, co-deprenyl treated (Ddep) transgenics. Note the presence of numerous retracted processes in the microglia in the Dox panel versus presence of ramified microglia in the No Dox and Ddep panels.
###end p 40
###begin title 41
Increases in astrocytic MAO-B activity results in decreased locomotor movement
###end title 41
###begin p 42
###xml 266 278 266 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g008">Figure 8A, B</xref>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
Finally, astrocytic increases in MAO-B in our model were found to correlate with a significant inhibition of locomotor function. Open field analysis of dox-treated mice revealed a significant difference in locomotor behavior in induced versus uninduced transgenics (Figure 8A, B). After treatment with dox alone for two weeks, induced mice displayed a approximately32-35% decrease in locomotor activity in comparison to uninduced littermates. In contrast, deprenyl-treated induced mice were completely unaffected.
###end p 42
###begin title 43
Elevation in astrocytic MAO-B results in loss of ambulatory movement in MAO-B transgenics.
###end title 43
###begin p 44
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 342 344 <span type="species:ncbi:10090">ND</span>
###xml 368 370 <span type="species:ncbi:10090">ND</span>
###xml 404 406 <span type="species:ncbi:10090">ND</span>
###xml 422 425 <span type="species:ncbi:10090">Dox</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
Total ambulatory velocity (A) and ambulatory distance (B) following two weeks of dox administration. Data is presented as average ambulatory velocity calculated over a 10 minute observation period and total ambulatory distance is for that same time interval. N = 5 mice per condition; experiments were run in triplicate. * p<0.01 compared to ND, ** p>0.05 compared to ND. Values are given for untreated (ND), dox-treated (Dox), and dox, deprenyl co-treated mice. Wildtype untreated littermates had an ambulatory velocity of 2.37+/-0.45 cm/s and a total ambulatory distance moved of 1082+/-101 cm.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Youdim1">[47]</xref>
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Olanow1">[51]</xref>
Increased brain MAO-B levels have been hypothesized to play a role in neuropathies associated with PD [47]-[51] however direct proof of a causative role has been thus far lacking. In this study, we demonstrate that elevations in astrocytic MAO-B levels results in a relatively selective loss of dopaminergic SN neurons and the severity of this loss appears to be age-dependent. It is not clear why there was not a more dramatic increase in SN DA cell loss with age in the MAO-B transgenics. Normally, cell loss coincides with an age-related increase in MAO-B enzyme activity. Our results suggest that perhaps the elevation of MAO-B to aging levels in the young animals was sufficient on its own to produce significant cell loss and that the additional stress of an aging brain contributed marginally (yet significantly) to this effect. Observed cell loss was accompanied by increased mitochondrial oxidative stress and selective decreases in mitochondrial complex I activity in these cells along with local microglial activation all of which we assume contribute to subsequent cell death. These pathological alterations were found to correlate with a significant decrease in locomotory behavior. Our data, taken in total, demonstrates that elevations in levels of astrocytic MAO-B activity results in several of key pathological hallmarks of Parkinson's disease.
###end p 46
###begin p 47
###xml 603 611 603 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g009">Figure 9</xref>
###xml 767 768 767 768 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 769 770 769 770 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
ROS produced by MAO-B-expressing astrocytes can be released into the extracellular environment and, due to its high membrane permeability, diffuse into neighboring cells. Within dopaminergic neurons, it can oxidize dopamine to DACHR which can interact with electrons at the auto-oxidizable site of mitochondrial complex I at a higher affinity than oxygen itself producing DACR radical. Electrons can then be transferred from DACR radical to oxygen resulting in re-reduction of DACR to DACHR and production of superoxide as part of an ongoing redox cycling event. These events are shown schematically in Figure 9. We have demonstrated in this current study that increased astrocytic MAO-B results in elevations in extracellular ROS levels and increased intracellular H2O2 within the terminals of SN dopaminergic neurons accompanied by increased dopamine oxidation to DACHR, selective mitochondrial complex I inhibition and elevations in mitochondrial superoxide levels. These events are prevented by either co-treatment with the MAO-B inhibitor deprenyl or the antioxidant compound EUK189 which also prevented subsequent dopaminergic SN cell loss.
###end p 47
###begin title 48
A schematic representation of the events occurring upon the elevation of glial MAO-B.
###end title 48
###begin p 49
###xml 62 63 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 64 65 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 150 151 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 152 153 152 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 238 239 238 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 240 242 240 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 409 410 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 411 412 411 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 863 864 863 864 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 865 866 865 866 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Increased astroglial levels of MAO-B results in elevation of H2O2 levels; this can be prevented by deprenyl. Astroglia are themselves protected from H2O2 due to relatively high levels of glutathione-gluathione peroxidase versus neurons. H2O2 can diffuse out of astroglia and into neighboring cells including local dopaminergic neurons and microglia; this can be prevented by EUK. Dopamine can be oxidized by H2O2 through dopamine quinone formation to stable dopaminochrome (DACHR). DACHR can extract an electron from the auto-oxidizable site of mitochondrial complex I forming DACR radical and impacting selectively on complex I function. Due its high affinity for molecular oxygen, DACR radical can pass an electron on to this molecular species resulting in its re-reduction to DACHR and increased formation of mitochondrial superoxide radical. MAO-B generated H2O2 can also stimulate local microglia; microglial activation can be greatly secondarily enhanced within the SN due to dopaminergic cell demise which can also exacerbate ROS production and impact on local dopaminergic neurons.
###end p 49
###begin p 50
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-McGeer1">[40]</xref>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Sherer1">[43]</xref>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Peng1">[44]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Cicchetti1">[52]</xref>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Sugama1">[54]</xref>
###xml 365 366 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Another prominent feature noted in our model was local microglial activation within the nigrostriatum. Dramatic local proliferation of microglial cells has been reported in the post-mortem PD brain as well as in various animal models of the disease [40], [43], [44], [52]-[54].Local microglial activation was found to be associated in our model with degenerating TH+ cells in both the SN and the striatum. It may be a secondary reaction to initiation of dopaminergic neurodegeneration. Significantly, dopaminergic SN cell loss is substantially attenuated by co-treatment of animals with the microglial activation inhibitor minocycline suggesting that microglial activation plays a significant role in dopaminergic demise associated with this model.
###end p 50
###begin p 51
###xml 446 451 <span type="species:ncbi:9606">human</span>
Taking in total, our data demonstrates a linkage between several separate pathological events associated with Parkinson's disease that have not necessarily been considered to be mechanistically connected including mitochondrial dysfunction, and microglial activation. This suggests that MAO-B may be a common initiator for these events and provides a novel model for exploring the mechanisms by which these events can occur in the context of the human condition.
###end p 51
###begin title 52
Materials and Methods
###end title 52
###begin title 53
Generation and analysis of transgenics with inducible astrocyte-specific elevation of MAO-B levels
###end title 53
###begin p 54
###xml 737 760 737 760 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;ACTGAACCCAAAGGCACAC3&#8242;</named-content>
###xml 765 791 765 791 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;AACATGACAATGAAGGAGCTAC3&#8242;</named-content>
###xml 807 827 807 827 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GCCTTTACCCATTACC3&#8242;</named-content>
###xml 832 854 832 854 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CCCGCTTATTTTTAATGC3&#8242;</named-content>
###xml 1959 1960 1955 1956 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2108 2111 2104 2107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Westlund2">[2]</xref>
###xml 2113 2117 2109 2113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Miller1">[55]</xref>
###xml 2270 2280 2266 2276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 258 263 <span type="species:ncbi:10090">mouse</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 435 440 <span type="species:ncbi:9606">human</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 1158 1163 <span type="species:ncbi:10090">mouse</span>
###xml 1320 1335 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1608 1613 <span type="species:ncbi:9606">human</span>
###xml 2204 2208 <span type="species:ncbi:10090">Mice</span>
Human MAO-B cDNA was cloned into pBIG (Clontech) at the PstI and SalI sites, placing the gene under transcriptional control of the bidirectional Tet-inducible promoter. A second construct was prepared which contained the 3.7 kb HinDIII-BamHI fragment of the mouse GFAP promoter cloned in EcoRI blunt ended pTetOn vector, driving expression of the Tet-responsive reverse transactivator rtTA. Transgenic C57Bl6 mice inducibly expressing human MAO-B selectively within astrocytes were produced by co-injecting the two transgenes into the male pronuclei of a fertilized egg prior to implantation into a pseudopregnant female. Subsequent founder mice were crossed with wildtype C57Bl6 and resulting litters genotyped by PCR using the primers 5'ACTGAACCCAAAGGCACAC3' and 5'AACATGACAATGAAGGAGCTAC3' for MAO-B, and 5'GCCTTTACCCATTACC3' and 5'CCCGCTTATTTTTAATGC3' for rTta. Littermates positive for both transgenes were mated to achieve homogeneous lines. Astroglial-specific transgene expression was induced by feeding animals doxycycline at 3000 ppm provided in pre-mixed Purina chow (Research Diets) for a three week period. Assuming a 5 g diet per day for a 30 g mouse, the dosage achieved was calculated to be equivalent to 0.5 g/kg/day. Total RNA was isolated from cortical brain tissue of wildtype uninduced and uninduced transgenic mice using Trizol (Invitrogen).according to manufacturer's instructions. cDNA was prepared using Superscript III reverse transcriptase kit (Invitrogen) and oligo-(dT) primers from 2 microg of total RNA. PCR was carried out with the forward and reverse primers corresponding to human MAO-B cDNA as above using Taq polymerase (Eppendorf). A 448bp amplicon indicates the induction of the h-MAO-B transcript. Positive transgene induction was also confirmed based on MAO-B and betagalactosidase positive-immunostaining within astrocytes of dox-induced transgenics using antibodies specific to hMAO-B and betagalactosidase within GFAP+ cells. Betagalactosidase and MAO-B enzyme activities were also performed in whole brain homogenates from induced versus uninduced transgenic lines [2], [55]. The line showing the highest level of induction was used for all subsequent studies. Mice were housed according to standard animal care protocols, fed ad libitum, kept on a 12 hr light/dark cycle, and maintained in a pathogen-free environment in the Buck Institute Vivarium. Animals used for subsequent studies were either young adults (2-6 months of age) or older animals (14 months of age) fed dox on the regime described above. Co-treatment with other agents involved intraperitoneal administrations of 10-30 mg/kg/day of deprenyl, minocycline or EUK-189 for two weeks.
###end p 54
###begin title 55
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
MPP+ measurements, striatal dopamine content cell counts and neurodegeneration in inducible astrocytic MAO-B transgenics versus controls +/- MPTP
###end title 55
###begin p 56
###xml 204 205 204 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Kaur1">[56]</xref>
###xml 812 813 812 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 869 873 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Kaur1">[56]</xref>
###xml 1189 1191 1177 1179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 1216 1217 1204 1205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1275 1276 1263 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1484 1485 1469 1470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1880 1884 1865 1869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Ochs1">[39]</xref>
Striatal tissue was harvested from dox versus untreated animals 90 minutes following injection of 30 mg/kg MPTP intraperitoneally, immediately immersed in ice cold 0.1 M perchloric acid and sonicated. MPP+ was measured by HPLC as previously described [56]. Dopamine levels were analyzed in striata dissected two weeks of induction or 24 hrs following MPTP injection post induction by HPLC followed by a 464 pulsed electrochemical detection (Neurochemistry Core, Center for Molecular Neuroscience, Vanderbilt University). Stereological cell counts were performed on immunostained brain sections from brains harvested two weeks after induction using either antibody against tyrosine hydroxylase (TH, Chemicon, 1:500) followed by biotin-labeled secondary antibody and development using DAB (Vector Laboratories). TH+ cells were counted stereologically throughout the SNpc [56]. Counts for dox removal were performed on brains dissected after removal of dox from the feed for a three week period. Sections were cut at a 40 microm thickness, and every 4th section was counted using a grid of 100x100 microm. Dissector size used was 35x35x12 microm. Neuronal numbers were assessed following NeuN+ (Chemicon, 1:100) or GABA+ (Chemicon, 1:1000) immunostaining and astrocytes via GFAP+ (DAKO, 1:500) and s100-beta (DAKO, 1:200) immunostaining. Cells were counted in the SN, striata, and cortex in three independent sections per condition and ten fields per section. Neurodegeneration in the TH+ cells was visualized by silver staining (FD Neurotechnologies, Ellicott City, MD) according to the manufacturer's instructions using proprietary compounds after immunostaining the sections with antibody against tyrosine hydroxylase (TH, Chemicon, 1:500) visualized with Vector Blue alkaline phosphatase (Vector labs). Dopaminochrome was measured from striatal samples by HPLC as per Ochs et al [39].
###end p 56
###begin title 57
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 17 18 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Extracellular H2O2 levels and dopaminergic cell survival in mesencephalic cultures
###end title 57
###begin p 58
###xml 500 504 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Smith1">[57]</xref>
###xml 595 596 585 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 731 735 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Kumar1">[22]</xref>
###xml 804 805 780 781 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 806 807 782 783 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1028 1029 1004 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1048 1049 1024 1025 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1109 1110 1085 1086 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1140 1141 1116 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1231 1232 1203 1204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1407 1408 1375 1376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1452 1453 1420 1421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1588 1590 1556 1558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Primary mixed cultures were prepared from the midbrain of 14-day-old mice embryos from MAO-B transgenics and WT controls. Tissue was digested in Neurobasal medium containing 30 U/ml papain and 20 microg/ml DNase at 37degreesC for 30 min and mechanically triturated. Dissociated cells were centrifuged at 500 x g, resuspended in growth medium (Neurobasal medium supplemented with 10% FBS, 2 mM glutamate, B25 supplement without antioxidants, 50 U/ml penicillin, 50 U/ml streptomycin and 50 ng/ml GDNF [57]), and plated on poly-d-lysine-coated 8 well chamber slides (BD-Biocoat) at a density of 105 cells per ml. Mixed cultures were grown at 37degreesC for 3-5 days before induction with 40 microg/ml doxycycline for 12 hours as per [22]. Cells were co-treated with 10 microM deprenyl or 500 nM apocynin. H2O2 in the medium was assayed by Amplex Red per the manufacturer's instructions. Dopaminergic and microglial cell counts were performed following fixation of the cultured cells for 15 min with 4% formaldehyde following by TH+ (Chemicon) or Iba1+(WAKO USA, Richmond, VA) immunostaining or via uptake of ASP+ (4-(4-(dimethylamino)styryl)-N- methylpyridinium iodide) (Invitrogen), a fluorescent analogue of dopamine. 10 microM ASP+ was loaded on to the uninduced or induced cultures in the presence of 20 microM of desipramine to inhibit the norepinephrine transporter which would also take up the dye. ASP+ fluorescence (red) was visualized in the TH+ cells after immunostaining with anti-TH antibody and Alexa fluor 488 conjugated secondary antibody. Averages of manual double blind TH+ or fluorescent counts of three wells of culture with the same treatment were collected; counts were performed in triplicate.
###end p 58
###begin title 59
Immuno-magnetic isolation of dopaminergic synaptosomes
###end title 59
###begin p 60
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Docherty1">[58]</xref>
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Budd1">[59]</xref>
###xml 271 277 <span type="species:ncbi:9986">rabbit</span>
###xml 330 336 <span type="species:ncbi:9986">rabbit</span>
Dopaminergic and non-dopaminergic striatal synaptosomes were isolated using a modified immuno-magnetic protocol [58]. Briefly, synaptosomes were prepared from dissected striatal tissue [59]. Dopaminergic synaptosomes were isolated using magnetic beads conjugated to anti-rabbit IgG (Miltenyi Biotech) after capturing them using a rabbit anti-DAT antibody (Chemicon). Under a magnetic field, bead-bound synaptosomes were passed through a column and washed; flow-through in the presence of the magnetic field yielded a fraction enriched in non-dopaminergic striatal synaptosomes. Elution performed in the absence of the magnetic field yielded fractions enriched in dopaminergic striatal synaptosomes. Equal quantities of various fractions of the synaptosomes isolated using DAT antibody including the starting material or control, the unbound fraction, the flow-through, the wash and the eluate were subjected to western analysis to assess relative dopaminergic versus non-dopaminergic synaptosomal purification. Western blots were performed using antibodies against TH (Chemicon 1:500), GABA (Chemicon, 1:1000) or SNAP-25 as a synaptic protein normalization control (Chemicon, 1:1000). Band densities were quantified using a Chemimager (Alpha Innotech, San Leandro, CA). Approximately 94% synaptosomes in the eluate were dopaminergic according to densitometric evaluation of the western blot.
###end p 60
###begin title 61
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
H2O2 estimation in synaptosomes
###end title 61
###begin p 62
###xml 344 348 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Andrews1">[38]</xref>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">Mice</span>
Hydrogen peroxide levels were measured in the striatal dopaminergic and non-dopaminergic synaptosomes prepared as above from various groups of mice. Mice were injected in the tail vein with approximately200 microl of DCFDA (Calbiochem) which was freshly diluted 100 x with PBS from a stock of 100 mg/ml in DMSO as modified from Andrews et. al. [38]. The animals were sacrificed 3 hours later and synaptosomes were prepared as above. Hydrogen peroxide in the synaptosomes with or without 1mg/ml catalase for 30 min after preparation was visualized as DCF fluorescence at 488 nm excitation and 512 nm emission in a Spectramax Gemini fluorescence plate reader. The relative fluorescence was normalized to synaptosomal protein which was quantified using the Bradford reagent, Bio-Rad.
###end p 62
###begin title 63
Mitochondrial complex I and IV activities
###end title 63
###begin p 64
###xml 487 491 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Trounce1">[60]</xref>
###xml 660 661 644 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Isolated synaptosomes were found to be physiologically viable for up to 3 hours. Complex I activities were assayed in isolated dopaminergic and non-dopaminergic synaptosomal fractions from dox-induced animals as rotenone-sensitive NADH dehydrogenase activity by measuring DCPIP (2,6-dichlorophenolindophenol) reduction in synaptosomal extracts following addition of 200 microM NADH, 200 microM decylubiquinone, 2 mM KCN, and 0.002% DCPIP in the presence and absence of 2 microM rotenone [60]. Complex IV activity was assayed as cytochrome c oxidase activity by observing the rapid (1-2s) oxidation of freshly reduced 40 microM ferrocytochrome c in a 10 mM K-PO4 buffer pH 7.2 containing 100 mM KCl, 0.025% maltoside at 30degreesC, at 550 nm, averaged over two concentrations per sample. Values for all assays were normalized/protein using BioRad reagent.
###end p 64
###begin title 65
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Detection of mitochondrial superoxide in vivo
###end title 65
###begin p 66
Mitosox Red (Molecular Probes) was used as an indicator to assess presence of superoxide within cellular mitochondria. 10 microg of Mitosox in 200 microl phosphate-buffered saline was injected into the tail vein of dox-induced transgenics versus controls. Animals were sacrificed 90 minutes later, brains rapidly dissected out and post-fixed overnight in 4% paraformaldehyde. Brains were sectioned at 30 microm using a cryostat. Cellular localization and site of Mitosox Red accumulation in the nigrostriatum was identified by immunofluorescence using anti-TH (Chemicon, 1:500), anti-IBA1 (Wako, 1:500) or anti-GFAP (DAKO, 1:500) antibodies visualized with Fluorescein Avidin D. Mitochondrial localization was confirmed by immunoanalysis using an anti-ATP synthase-specific antibody. Fluorescent imaging was done using a Zeiss LSM510 NLO confocal microscope and images procured using LSM software. Quantification of colocalization and fluorescent intensity was determined using the IMARIS software suite (Bitplane AG, Zurich, Switzerland) on selected cells from multiple sections.
###end p 66
###begin title 67
Morphological analyses of astrocyte and microglial activation
###end title 67
###begin p 68
###xml 317 322 <span type="species:ncbi:9796">Horse</span>
###xml 323 329 <span type="species:ncbi:3726">radish</span>
Immunochemistry was performed on cryosections derived from the SN, striata, and CTX of fixed perfused brains from dox-induced transgenics versus controls. Astrocytic activation was assessed using primary antibodies against GFAP and s100-beta. Microglial activation was detected using primary antibodies against Iba1. Horse radish peroxidase or avidin-conjugated secondary antibodies were used to detect primary antibodies following either DAB or Fluorescein/Texas Red staining.
###end p 68
###begin title 69
Locomotor behavioral assessment
###end title 69
###begin p 70
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001616-Peng2">[61]</xref>
###xml 402 417 <span type="species:ncbi:10090">transgenic mice</span>
Locomotor function was assessed using an automated Truscan photobeam apparatus (Colbourne Instruments, Allentown, PA) under illumination as previously described [61]. Animals were habituated to the apparatus for 10 min then data collected over a 10-min period followed by analysis using Truscan 99 software. Spontaneous horizontal movement was assessed in both control and dox treated versus untreated transgenic mice via both ambulatory velocity and distance in a 10-min period.
###end p 70
###begin title 71
Supporting Information
###end title 71
###begin p 72
###xml 387 395 387 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001616-g006">Figure 6</xref>
Microglial activation is largely absent in the cortex. Absence of detectable microglial activation in the cortical sections from untreated, dox-treated deprenyl co-treated animals. Iba1 immunocytochemistry reveals that cortical microglia are in a resting ramified stage in all the three types of treatments conditions in contrast to what occurs in the striatum and the substantia nigra (Figure 6). This suggests that activation in the nigrostriatum may largely be due to secondary effects as a consequence of SN dopaminergic demise. Two representative micrographs are provided from each treatment.
###end p 72
###begin p 73
(10.35 MB TIF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
###xml 168 169 168 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
We thank Raymond Johnson (Vanderbilt University, Nashville Tennessee) for measurement of dopamine content and Martha Isla (Parkinson's Institute, Sunnyvale, CA) for MPP+ measurements.
###end p 75
###begin title 76
References
###end title 76
###begin article-title 77
###xml 89 94 <span type="species:ncbi:9606">human</span>
Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem.
###end article-title 77
###begin article-title 78
Distinct monoamine oxidase A and B populations in primate brain.
###end article-title 78
###begin article-title 79
Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons.
###end article-title 79
###begin article-title 80
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Age-related changes on MAO in Bl/C57 mouse tissues: a quantitative radioautographic study.
###end article-title 80
###begin article-title 81
###xml 62 67 <span type="species:ncbi:9606">human</span>
The effect of age on the activity and molecular properties of human brain monoamine oxidase.
###end article-title 81
###begin article-title 82
###xml 35 40 <span type="species:ncbi:9606">human</span>
Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl.
###end article-title 82
###begin article-title 83
Pharmacology of selegiline.
###end article-title 83
###begin article-title 84
Dopamine induces ERK activation in renal epithelial cells through H2O2 produced by monoamine oxidase.
###end article-title 84
###begin article-title 85
Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow.
###end article-title 85
###begin article-title 86
Oxygen free radicals and Parkinson's disease.
###end article-title 86
###begin article-title 87
Reactive oxygen species and the central nervous system.
###end article-title 87
###begin article-title 88
Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons.
###end article-title 88
###begin article-title 89
Maintenance of neuronal glutathione by glial cells.
###end article-title 89
###begin article-title 90
###xml 111 116 <span type="species:ncbi:9031">chick</span>
Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain.
###end article-title 90
###begin article-title 91
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
Cloning/brain localization of mouse glutamylcysteine synthetase heavy chain mRNA.
###end article-title 91
###begin article-title 92
Oxidative stress in a clonal cell line of neuronal origin: effects of antioxidant enzyme modulation.
###end article-title 92
###begin article-title 93
Hydrogen peroxide mediates amyloid beta protein toxicity.
###end article-title 93
###begin article-title 94
###xml 75 78 <span type="species:ncbi:10116">rat</span>
Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons.
###end article-title 94
###begin article-title 95
Genetic elevation of monoamine oxidase levels in dopaminergic PC12 cells results in increased free radical damage and sensitivity to MPTP.
###end article-title 95
###begin article-title 96
Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?
###end article-title 96
###begin article-title 97
###xml 69 74 <span type="species:ncbi:9606">human</span>
Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain.
###end article-title 97
###begin article-title 98
Oxidative alpha-ketoglutarate dehydrogenase inhibition via subtle elevations in monoamine oxidase B levels results in loss of spare respiratory capacity: implications for Parkinson's disease.
###end article-title 98
###begin article-title 99
Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
###end article-title 99
###begin article-title 100
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease.
###end article-title 100
###begin article-title 101
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.
###end article-title 101
###begin article-title 102
Suppression of hydroxyl radical formation and protection of nigral neurons by l-deprenyl (selegiline).
###end article-title 102
###begin article-title 103
(-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
###end article-title 103
###begin article-title 104
Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites.
###end article-title 104
###begin article-title 105
An interim report of the effect of selegiline (L-deprenyl) on the progression of disability in early Parkinson's disease. The Parkinson Study Group.
###end article-title 105
###begin article-title 106
Clinical trials of neuroprotection in Parkinson's disease: long-term selegiline and alpha-tocopherol treatment.
###end article-title 106
###begin article-title 107
DATATOP-study: significance of its results in the treatment of Parkinson's disease.
###end article-title 107
###begin article-title 108
Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Parkinson Study Group.
###end article-title 108
###begin article-title 109
Ageing and Parkinson's disease: substantia nigra regional selectivity.
###end article-title 109
###begin article-title 110
Dopamine-derived dopaminochrome promotes H(2)O(2) release at mitochondrial complex I: stimulation by rotenone, control by Ca(2+), and relevance to Parkinson disease.
###end article-title 110
###begin article-title 111
###xml 79 83 <span type="species:ncbi:10116">rats</span>
Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxydopamine.
###end article-title 111
###begin article-title 112
Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine.
###end article-title 112
###begin article-title 113
The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons.
###end article-title 113
###begin article-title 114
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease.
###end article-title 114
###begin article-title 115
The separation and quantification of aminochromes using high-pressure liquid chromatography with electrochemical detection.
###end article-title 115
###begin article-title 116
Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.
###end article-title 116
###begin article-title 117
###xml 70 76 <span type="species:ncbi:9606">humans</span>
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure.
###end article-title 117
###begin article-title 118
Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
###end article-title 118
###begin article-title 119
Mechanism of toxicity in rotenone models of Parkinson's disease.
###end article-title 119
###begin article-title 120
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Nigrostriatal dopaminergic neurodegeneration in the weaver mouse is mediated via neuroinflammation and alleviated by minocycline administration.
###end article-title 120
###begin article-title 121
Intracellular signaling in M-CSF-induced microglia activation: role of Iba1.
###end article-title 121
###begin article-title 122
Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices.
###end article-title 122
###begin article-title 123
Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness.
###end article-title 123
###begin article-title 124
Neuroprotective strategies in Parkinson's disease : an update on progress.
###end article-title 124
###begin article-title 125
###xml 105 109 <span type="species:ncbi:10090">mice</span>
The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessment.
###end article-title 125
###begin article-title 126
The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence.
###end article-title 126
###begin article-title 127
A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease.
###end article-title 127
###begin article-title 128
###xml 98 102 <span type="species:ncbi:10116">rats</span>
Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.
###end article-title 128
###begin article-title 129
###xml 107 110 <span type="species:ncbi:9685">cat</span>
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain.
###end article-title 129
###begin article-title 130
###xml 139 143 <span type="species:ncbi:10090">mice</span>
Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice.
###end article-title 130
###begin article-title 131
Experiments in Molecular Genetics,
###end article-title 131
###begin article-title 132
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.
###end article-title 132
###begin article-title 133
Discrepant effects of culture conditions on survival and function of dopaminergic neurons.
###end article-title 133
###begin article-title 134
###xml 45 48 <span type="species:ncbi:10116">rat</span>
Isolation of monoaminergic synaptosomes from rat brain by immunomagnetophoresis.
###end article-title 134
###begin article-title 135
Protein kinase C-mediated suppression of the presynaptic adenosine A1 receptor by a facilitatory metabotropic glutamate receptor.
###end article-title 135
###begin article-title 136
###xml 57 64 <span type="species:ncbi:9606">patient</span>
Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines.
###end article-title 136
###begin article-title 137
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
Inhibition of caspases protects cerebellar granule cells of the weaver mouse from apoptosis and improves behavioral phenotype.
###end article-title 137
###begin article-title 138
Development and characterization of a conditional mitochondrial complex I assembly system.
###end article-title 138
###begin p 139
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 139
###begin p 140
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: These studies were funded via R01 NS40057-04 (JKA) and the National Parkinson's Foundation (JKM).
###end p 140

